Copyright © 1999 by the European Society of Cardiology.
The effect of physical training on hormonal status and exertional hormonal response in patients with chronic congestive heart failure
a Department of Medicine, Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland
b Department of Clinical Chemistry, Helsinki University Central Hospital, Helsinki, Finland
revised July 28, 1998; accepted July 29, 1998
Abstract
Background
Physical training improves exercise capacity in patients with chronic heart failure. It decreases plasma noradrenaline at rest, which may be prognostically favourable. The effect on atrial natriuretic peptide, another prognostic factor, and on catabolic and anabolic hormones remains unknown. Furthermore, to our knowledge, the contribution of exertional hormonal responses to the improved exercise capacity has not been evaluated.
Methods
27 patients with stable chronic heart failure (New York Heart Association class IIIII) were randomized to training (n=12) and control (n=15) groups. The training group exercised on a bicycle ergometer for 30min three times a week for 3 months. The load corresponded to 5060% of their peak oxygen consumption. For the next 3 months they exercised at home according to personal instructions. The control group did not change its physical activities. The levels of hormones regulating the cardio-vascular system and metabolism were determined at rest and after graded maximal exercise and during exercise with constant submaximal workload.
Results
Submaximal exercise capacity increased significantly and peak oxygen consumption tended to improve by 12% in the training group. The plasma noradrenaline at rest tended to decrease by 19%. The plasma level of N-terminal pro atrial natriuretic peptide did not change. Serum cortisol, a catabolic hormone, was normal at baseline and remained unchanged. The serum levels of anabolic hormones, growth hormone and insulin, as well as dehydro-epiandrosteronesulfate and free testosterone were within a normal range at baseline. They were not altered by training. The dehydroepiandrosteronesulfate/cortisol, and the free testosterone/cortisol ratios, reflecting anabolic/catabolic balance, did not change, either. Training resulted in a higher peak noradrenaline response during graded maximal exercise. The rise in serum cortisol during exercise tended to attenuate.
Conclusion
Physical training, which improves exercise capacity, does not have an unfavourable effect on anabolic/catabolic balance or neurohumoral activation in patients with congestive heart failure. It decreases plasma noradrenaline at rest. Minor changes in hormonal responses during exercise emerged after physical training which unlikely contribute to the improved exercise capacity.
Key Words: Anabolism, catabolism, congestive heart failure, hormones, physical training
f1 Correspondence: Dr K. Kiilavuori, Department of Medicine, Jorvi Hospital, Turuntie 150, 02740 Espoo, Finland.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Xing, J. Lu, and J. Li Contribution of nerve growth factor to augmented TRPV1 responses of muscle sensory neurons by femoral artery occlusion Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1380 - H1387. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-K. Tai, J. C. Meininger, and L. Q. Frazier A Systematic Review of Exercise Interventions in Patients With Heart Failure Biol Res Nurs, October 1, 2008; 10(2): 156 - 182. [Abstract] [PDF] |
||||
![]() |
J. Xing, Z. Gao, J. Lu, L. I. Sinoway, and J. Li Femoral artery occlusion augments TRPV1-mediated sympathetic responsiveness Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1262 - H1269. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gao, W. Wang, D. Liu, and I. H. Zucker Exercise Training Normalizes Sympathetic Outflow by Central Antioxidant Mechanisms in Rabbits With Pacing-Induced Chronic Heart Failure Circulation, June 19, 2007; 115(24): 3095 - 3102. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A.F. van Tol, R. J. Huijsmans, D. W. Kroon, M. Schothorst, and G. Kwakkel Effects of exercise training on cardiac performance, exercise capacity and quality of life in patients with heart failure: A meta-analysis Eur J Heart Fail, December 1, 2006; 8(8): 841 - 850. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ikeda, K.-i. Aihara, T. Sato, M. Akaike, M. Yoshizumi, Y. Suzaki, Y. Izawa, M. Fujimura, S. Hashizume, M. Kato, et al. Androgen Receptor Gene Knockout Male Mice Exhibit Impaired Cardiac Growth and Exacerbation of Angiotensin II-induced Cardiac Fibrosis J. Biol. Chem., August 19, 2005; 280(33): 29661 - 29666. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Niebauer, A. L. Clark, K. M. Webb-Peploe, and A. J.S. Coats Exercise training in chronic heart failure: effects on pro-inflammatory markers Eur J Heart Fail, March 2, 2005; 7(2): 189 - 193. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Y. Liu, A. K. Death, and D. J. Handelsman Androgens and Cardiovascular Disease Endocr. Rev., June 1, 2003; 24(3): 313 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. L. Pina, C. S. Apstein, G. J. Balady, R. Belardinelli, B. R. Chaitman, B. D. Duscha, B. J. Fletcher, J. L. Fleg, J. N. Myers, and M. J. Sullivan Exercise and Heart Failure: A Statement From the American Heart Association Committee on Exercise, Rehabilitation, and Prevention Circulation, March 4, 2003; 107(8): 1210 - 1225. [Full Text] [PDF] |
||||
![]() |
M. Pietila, K. Malminiemi, R. Vesalainen, T. Jartti, M. Teras, K. Nagren, P. Lehikoinen, and L.-M. Voipio-Pulkki Exercise Training in Chronic Heart Failure: Beneficial Effects on Cardiac 11C-Hydroxyephedrine PET, Autonomic Nervous Control, and Ventricular Repolarization J. Nucl. Med., June 1, 2002; 43(6): 773 - 779. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Geny, R. Richard, B. Mettauer, J. Lonsdorfer, and F. Piquard Cardiac natriuretic peptides during exercise and training after heart transplantation Cardiovasc Res, August 15, 2001; 51(3): 521 - 528. [Full Text] [PDF] |
||||
![]() |
A Baartscheer Adenovirus gene transfer of SERCA in heart failure. A promising therapeutic approach ? Cardiovasc Res, February 1, 2001; 49(2): 249 - 252. [Full Text] [PDF] |
||||
![]() |
R. Palusinski, W. Barud, T. O'Gara, K. Ullis, T. N. Ziegenfuss, R. Cohen, W. D. Brink, W. J. Roberts, D. S. King, R. L. Sharp, et al. Effects of Androstenedione in Young Men JAMA, February 9, 2000; 283(6): 741 - 743. [Full Text] [PDF] |
||||








